Reported Positive Data in First Pivotal Phase 3 Trial for Nyxol Eye Drops with Plans to Advance Towards NDA Submission and Commercialization in Reversal of Mydriasis Indication […]
Interview with Rob Fia, CEO […]
Toronto, Ontario–(Newsfile Corp. – April 30, 2021) – City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) (“City View” or the “Company”), trading through the facilities of the Canadian Securities Exchange (“CSE“) under the symbol […]
Toronto, CANADA, April 28, 2021 – Argo Gold Inc. (“Argo Gold”) (CSE: ARQ) (OTCQB: ARBTF) commenced surface exploration at the Uchi Gold Project in April 2021, and the bedrock stripping, trenching, washing, geological mapping and channel sampling will continue in […]
Vancouver, BC ‐ ArcPacific Resources Corp. (“ACP” or the “Company”) (TSX-V: ACP) is pleased to announce that eight holes have now been completed at its Rickard Gold Project (the “Property”). Holes 5 through 8 (ACP-R-21005 – ACP-R-21008) have continued to […]
New Data from Physiological-Based Pharmacokinetic (PBPK) Model Supports APX3330 Oral Dose for the Ongoing ZETA-1 Phase 2 Trial […]
Vancouver, BC ‐ ArcPacific Resources Corp. (“ACP” or the “Company”) (TSX-V: ACP) is pleased to announce that four holes have now been completed at its Rickard Gold Project (the “Property”). The holes all intersected multiple […]
APX3330 has the Potential to be a Novel Oral Treatment Option with Dual Mechanism of Anti-VEGF and Anti-Inflammatory for Diabetic Retinopathy Top Line Data from ZETA-1 Expected by Early 2022 FARMINGTON HILLS, Mich., April 08, 2021 (GLOBE […]
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest”), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced […]
HaluGen’s DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com